参考文献/References:
[1].中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志,2021,36(6):521-545.
[2].李延广,王玉堂. 非瓣膜性心房颤动脑卒中风险评估进展[J]. 中华心律失常学杂志,2020,24(4):372-375.
[3].Dainis AM,Ashley EA. Cardiovascular precision medicine in the genomics era[J]. JACC Basic Transl Sci,2018,3(2):313-326.
[4].Yao JL,Zhou YF,Yang XJ,et al. KCNN3 SNP rs13376333 on chromosome 1q21 confers increased risk of atrial fibrillation[J]. Int Heart J,2015,56(5):511-515.
[5].Gudbjartsson DF,Arnar DO,Helgadottir A,et al. Variants conferring risk of atrial fibrillation on chromosome 4q25[J]. Nature,2007,448(7151):353-357.
[6].王旭,聂亚莉,宁姝威,等. 中国中原地区汉族人群染色体4q25上rs17042171与心房颤动有关[J].中南大学学报(医学版),2018,43(6):594-603.
[7].Zhou J,Gao J,Liu Y,et al. Human atrium transcript analysis of permanent atrial fibrillation[J]. Int Heart J,2014,55(1):71-77.
[8].Zhang J,Huang X,Wang X,et al. Identification of potential crucial genes in atrial fibrillation:a bioinformatic analysis[J]. BMC Med Genomics,2020,13(1):104.
[9].Zou R,Zhang D,Lv L,et al. Bioinformatic gene analysis for potential biomarkers and therapeutic targets of atrial fibrillation-related stroke[J]. J Transl Med,2019,17(1):45.
[10].Zhang YF,Meng LB,Hao ML,et al. Identification of co-expressed genes between atrial fibrillation and stroke[J]. Front Neurol,2020,11:184.
[11].梁士楚,王翠,宋晨宇,等. 心房颤动射频消融术后长期抗凝可行性及安全性的Meta分析和试验序贯分析[J]. 中国循环杂志,2020,35(11):1121-1128.
[12].王启鑫,任澎. 基因多态性对指导华法林应用的研究进展[J]. 心血管病学进展,2018,39(3):479-482.
[13].Calkins H,Kuck KH,Cappato R,et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation:recommendations for patient selection,procedural techniques,patient management and follow-up,definitions,endpoints,and research trial design[J]. J Interv Card Electrophysiol,2012,33(2):171-257.
[14].赵磊,梁兆光. 导管消融术后心房颤动复发的危险因素及预防[J]. 心血管病学进展,2019,40(5):766-769.
[15].谷蕾,陈效安,张卫泽,等. 心房颤动相关的小RNA的研究进展[J]. 心血管病学进展,2020,41(6):622-626.
[16].Salmena L,Poliseno L,Tay Y,et al. A ceRNA hypothesis:the Rosetta Stone of a hidden RNA language?[J]. Cell ,2011,146(3):353-358.
[17].Théry C,Zitvogel L,Amigorena S. Exosomes:composition,biogenesis and function[J]. Nat Rev Immunol,2002,2(8):569-579.
[18].Mun D,Kim H,Kang JY,et al. Expression of miRNAs in circulating exosomes derived from patients with persistent atrial fibrillation[J]. FASEB J,2019,33(5):5979-5989.
[19].Liu L,Chen Y,Shu J,et al. Identification of microRNAs enriched in exosomes in human pericardial fluid of patients with atrial fibrillation based on bioinformatic analysis[J]. J Thorac Dis,2020,12(10):5617-5627.
[20].Wang H,Chen Y,Tao T,et al. Identification of microRNA biomarkers in serum of patients at different stages of atrial fibrillation[J]. Heart Lung,2020,49(6):902-908.
[21].Hu X,Chen L,Wu S,et al. Integrative analysis reveals key circular RNA in atrial fibrillation[J]. Front Genet,2019,10:108.
[22].Zhang Y,Ke X,Liu J,et al. Characterization of circRNA-associated ceRNA networks in patients with nonvalvular persistent atrial fibrillation[J]. Mol Med Rep,2019,19(1):638-650.
[23].Zhang Y,Shen H,Wang P,et al. Identification and characterization of circular RNAs in atrial appendage of patients with atrial fibrillation[J]. Exp Cell Res,2020,389(2):111821.
[24].Wu J,Han D,Shi R,et al. Identification of atrial fibrillation-associated lncRNAs in atria from patients with rheumatic mitral valve disease[J]. Microsc Res Tech,2019,82(7):1136-1144.
[25].Cao F,Li Z,Ding WM,et al. LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation[J]. Mol Med,2019,25(1):7.
[26].Xu Y,Huang R,Gu J,et al. Identification of long non-coding RNAs as novel biomarker and potential therapeutic target for atrial fibrillation in old adults[J]. Oncotarget,2016,7(10):10803-10811.
[27].Wu N,Li J,Chen X,et al. Identification of long non-coding RNA and circular RNA expression profiles in atrial fibrillation [J]. Heart Lung Circ,2020,29(7):e157-e167.
[28].Monti C,Zilocchi M,Colugnat I,et al. Proteomics turns functional[J]. J Proteomics,2019,198:36-44.
[29].赵云飞,杨东辉. 代谢紊乱参与心房颤动机制的研究进展[J]. 心血管病学进展,2021,42(12):1085-1088.
[30].Bentley R,Logantha SJRJ,Sharma P,et al. Pathophysiological insights into atrial fibrillation: revisiting the electrophysiological substrate,anatomical substrate,and possible insights from proteomics[J]. Cardiovasc Res,2021,117(3):e41-e45.
[31].涂涛,刘启明,周胜华,等. 瓣膜性心脏病伴慢性心房颤动患者心房组织呼吸链相关蛋白质定量蛋白质组学分析[J]. 中华心律失常学杂志,2014,18(5):372-377.
[32].Baharum SN,Azizan KA. Metabolomics in systems biology[J]. Adv Exp Med Biol,2018,1102:51-68.
[33].Lai S,Hua X,Gao R,et al. Combinational biomarkers for atrial fibrillation derived from atrial appendage and plasma metabolomics analysis[J]. Sci Rep,2018,8(1):16930.
[34].Zuo K,Li J,Li K,et al. Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation[J]. Gigascience,2019,8(6):giz058.
[35].Zuo K,Yin X,Li K,et al. Different types of atrial fibrillation share patterns of gut microbiota dysbiosis[J]. mSphere ,2020,5(2):e00071-e00020.
[36].左琨,张婧,房辰,等. 基于宏基因组学的心房颤动患者肠道菌群脂多糖合成功能研究[J]. 中华心血管病杂志,2022,50(3):249-256.
[37].Mayerhoefer ME,Materka A,Langs G,et al. Introduction to adiomics[J]. J Nucl Med,2020,61(4):488-495.
[38].Ebrahimian S,Digumarthy SR,Homayounieh F,et al. Use of radiomics to differentiate left atrial appendage thrombi and mixing artifacts on single-phase CT angiography[J]. Int J Cardiovasc Imaging,2021,37(6):2071-2078.
[39].Chun SH,Suh YJ,Han K,et al. Differentiation of left atrial appendage thrombus from circulatory stasis using cardiac CT radiomics in patients with valvular heart disease[J]. Eur Radiol,2021,31(2):1130-1139.
[40].Yang M,Cao Q,Xu Z,et al. Development and validation of a machine learning-based radiomics model on cardiac computed tomography of epicardial adipose tissue in predicting characteristics and recurrence of atrial fibrillation[J]. Front Cardiovasc Med,2022,9:813085.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(9):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(9):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(9):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(9):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(9):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]